Advanced search
Publication Cover
Cancer Management and Research Volume 10, 2018 - Issue
Submit an article Journal homepage
17
Views
9
CrossRef citations to date
0
Altmetric
Original Research

RETRACTED ARTICLE: MicroRNA-365 targets multiple oncogenes to inhibit proliferation, invasion, and self-renewal of aggressive endometrial cancer cells

Chunfang WangDepartment of Gynecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China, [email protected]
,
Ke SuDepartment of Gynecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China, [email protected]
,
Yanyan ZhangDepartment of Gynecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China, [email protected]
,
Weiwei ZhangDepartment of Gynecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China, [email protected]
,
Danxia ChuDepartment of Gynecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China, [email protected]
,
Qian ZhaoDepartment of Gynecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China, [email protected]
&
Ruixia GuoDepartment of Gynecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China, [email protected]Correspondence[email protected]
 show all
Pages 5171-5185 | Published online: 30 Oct 2018

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Hai-bo Wu, Chen-si Yang, Yun-can Wang, Yue-tao Xie, Xue-chao Wang, Hui-liang Liu & Rong-pin Du. (2021) The Expression of miR-365 in Serum of Hypertension Patients with Left Ventricular Hypertrophy Was Up-Regulated, Which Was Positively Correlated with Left Ventricular Mass Index. Pharmacogenomics and Personalized Medicine 14, pages 905-913.
Read now
Kenneth K.W. To, Winnie Fong, Christy W.S. Tong, Mingxia Wu, Wei Yan & William C.S. Cho. (2020) Advances in the discovery of microRNA-based anticancer therapeutics: latest tools and developments. Expert Opinion on Drug Discovery 15:1, pages 63-83.
Read now

Articles from other publishers (7)

Lovlesh Thakur & Sunil Thakur. (2023) The interplay of sex steroid hormones and microRNAs in endometrial cancer: current understanding and future directions. Frontiers in Endocrinology 14.
Crossref
Xue Yang, Chaojie Li & Yuping Chen. (2023) Phosphoserine Aminotransferase 1: A Metabolic Enzyme Target of Cancers. Current Cancer Drug Targets 23:3, pages 171-186.
Crossref
Dan Hong, Aimin Zang, Zhiyu Wang, Lin Yang, Guanying Ren, Chong Zhang, Liwei Zhang, Wei Hou & Yaning Wei. (2022) Elevation of microRNA-365 impedes malignant behaviors of gastric cancer cells by inhibiting PAX6. Functional & Integrative Genomics 22:5, pages 825-834.
Crossref
Klaudia Klicka, Tomasz M. Grzywa, Alicja Klinke, Aleksandra Mielniczuk & Paweł K. Włodarski. (2021) The Role of miRNAs in the Regulation of Endometrial Cancer Invasiveness and Metastasis—A Systematic Review. Cancers 13:14, pages 3393.
Crossref
Matthew L. Potter, William D. Hill, Carlos M. Isales, Mark W. Hamrick & Sadanand Fulzele. (2021) MicroRNAs are critical regulators of senescence and aging in mesenchymal stem cells. Bone 142, pages 115679.
Crossref
Seung Wan Son, Han Yeoung Lee, Sokviseth Moeng, Hyo Jeong Kuh, Soo Young Choi & Jong Kook Park. (2020) Participation of MicroRNAs in the Treatment of Cancer with Phytochemicals. Molecules 25:20, pages 4701.
Crossref
Natalia García-Sancha, Roberto Corchado-Cobos, Jesús Pérez-Losada & Javier Cañueto. (2019) MicroRNA Dysregulation in Cutaneous Squamous Cell Carcinoma. International Journal of Molecular Sciences 20:9, pages 2181.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.